EFFECTS ON CYP27 MESSENGER-RNA EXPRESSION IN RAT-KIDNEY AND LIVER BY 1-ALPHA,25-DIHYDROXYVITAMIN D-3, A SUPPRESSOR OF RENAL 25-HYDROXYVITAMIN D-3 1-ALPHA-HYDROXYLASE ACTIVITY

被引:16
|
作者
AXEN, E
POSTLIND, H
WIKVALL, K
机构
[1] Univ Uppsala, Dept Pharmaceut Biosci, Div Biochem, S 75123 Uppsala
关键词
D O I
10.1006/bbrc.1995.2443
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The production of 1 alpha,25-dihydroxyvitamin D-3 is known to be down regulated by 1 alpha,25-dihydroxyvitamin D-3 itself. It was recently shown that liver mitochondrial sterol 27-hydroxylase CYP27, present also in kidney, catalyzes 1 alpha-hydroxylation of 25-hydroxyvitamin D-3. Treatment of vitamin D-deficient rats with a single i.v, dose of 1 alpha,25-dihydroxyvitamin D-3 resulted in a marked suppression of CYP27 mRNA in kidney. The effects were not as pronounced as for CYP24. Liver CYP27 was not affected to the same extent. The results of the present communication indicate a coordinate regulation of CYP27 mRNA levels and 25-hydroxyvitamin D-3 1 alpha-hydroxylase activity by 1 alpha,25-dihydroxyvitalnin D-3 in rat kidney. (C) 1995 Academic Press, Inc.
引用
收藏
页码:136 / 141
页数:6
相关论文
共 50 条
  • [31] Fluorimetric assay of 1 alpha,25-dihydroxyvitamin D-3 in human plasma
    Shimizu, M
    Wang, XX
    Yamada, S
    JOURNAL OF CHROMATOGRAPHY B, 1997, 690 (1-2): : 15 - 23
  • [32] 1 alpha,25-dihydroxyvitamin D-3; Its role for homeostasis of keratinocytes
    Wu, SL
    Geilen, CC
    Tebbe, B
    Orfanos, CE
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 1996, 7 (12): : 642 - 649
  • [33] Functional conformations of the nuclear 1 alpha,25-dihydroxyvitamin D-3 receptor
    Nayeri, S
    Carlberg, C
    BIOCHEMICAL JOURNAL, 1997, 327 : 561 - 568
  • [34] Role of 1 alpha,25-dihydroxyvitamin D-3 in osteoclast differentiation and function
    Suda, T
    Jimi, E
    Nakamura, I
    Takahashi, N
    VITAMINS AND COENZYMES, PT L, 1997, 282 : 223 - 235
  • [35] Cytotoxic effects of 1 alpha,25-dihydroxyvitamin D-3 and synthetic vitamin D-3 analogues on a glioma cell line
    Baudet, C
    Chevalier, G
    Naveilhan, P
    Binderup, L
    Brachet, P
    Wion, D
    CANCER LETTERS, 1996, 100 (1-2) : 3 - 10
  • [36] DIFFERENCES IN METABOLISM BETWEEN 26,26,26,27,27,27-HEXAFLUORO-1-ALPHA,25-DIRYDROXYVITAMIN D-3 AND 1-ALPHA,25-DIHYDROXYVITAMIN D-3 IN CULTURED NEONATAL MOUSE CALVARIA
    HARADA, M
    MIYAHARA, T
    KAJITAKONDO, S
    KOZAKAI, A
    HIGUCHI, S
    OTOMO, S
    KOZUKA, H
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1994, 86 (02) : 183 - 193
  • [37] COMPARATIVE EFFECTS OF 1,25-DIHYDROXYVITAMIN D-3 AND EB-1089 ON MOUSE RENAL AND INTESTINAL 25-HYDROXYVITAMIN D-3-24-HYDROXYLASE
    ROY, S
    MARTEL, J
    TENENHOUSE, HS
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 (12) : 1951 - 1959
  • [38] MOUSE PRIMARY OSTEOBLASTS EXPRESS VITAMIN-D-3 25-HYDROXYLASE MESSENGER-RNA AND CONVERT 1-ALPHA-HYDROXYVITAMIN-D-3 INTO 1-ALPHA,25-DIHYDROXYVITAMIN-D-3
    ICHIKAWA, F
    SATO, K
    NANJO, M
    NISHII, Y
    SHINKI, T
    TAKAHASHI, N
    SUDA, T
    BONE, 1995, 16 (01) : 129 - 135
  • [39] A NOVEL SYNTHESIS OF 19-NOR 1-ALPHA,25-DIHYDROXYVITAMIN D-3 AND RELATED ANALOGS
    HUANG, PQ
    SABBE, K
    POTTIE, M
    VANDEWALLE, M
    TETRAHEDRON LETTERS, 1995, 36 (45) : 8299 - 8302
  • [40] ON THE SIDE-CHAIN CONFORMATION OF 1-ALPHA,25-DIHYDROXYVITAMIN D-3 RESPONSIBLE FOR BINDING TO THE RECEPTOR
    YAMAMOTO, K
    OHTA, M
    DELUCA, HF
    YAMADA, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (09) : 979 - 984